ロード中...
Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor qualit...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Limited
2018-01-01
|
| シリーズ: | Case Reports in Pediatrics |
| オンライン･アクセス: | http://dx.doi.org/10.1155/2018/3514645 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|